APA (7th ed.) Citation

Tiezzi, D. G., Buzatto, I. P. C., da Silveira, W. A., Monti, A. C., Buono, F. d. O., Meola, J., . . . Pagnotta, S. M. (2025). The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy. International Journal of Molecular Sciences, 26(24), 11809. https://doi.org/10.3390/ijms262411809

Chicago Style (17th ed.) Citation

Tiezzi, Daniel Guimarães, Isabela Panzeri Carlotti Buzatto, Willian Abraham da Silveira, Anna Clara Monti, Fabiana de Oliveira Buono, Juliana Meola, Omero Benedicto Poli-Neto, and Stefano Maria Pagnotta. "The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy." International Journal of Molecular Sciences 26, no. 24 (2025): 11809. https://doi.org/10.3390/ijms262411809.

MLA (9th ed.) Citation

Tiezzi, Daniel Guimarães, et al. "The HER2MtGx Metagene Score as a Reliable Tool to Select HER2 Breast Cancer Patients for Neoadjuvant Targeted Therapy." International Journal of Molecular Sciences, vol. 26, no. 24, 2025, p. 11809, https://doi.org/10.3390/ijms262411809.